摘要
目的 观察倍他乐克对慢性心衰(CHF)的临床疗效。方法 将42例CHF患者随机分为倍他乐克组22例;常规治疗组20例;其中心肌病10例,冠心病32例。倍他乐克组在常规抗心衰治疗的基础上加用倍他乐克;常规治疗组则用强心利尿ACEI常规抗心衰治疗。结果 倍他乐克组心功能明显改善,总有效率达86%,与对照组比较有显著差异(P〈0.05),平均心率较对照组明显减慢(P〈0.005)。结论 倍他乐克对慢性心衰有显著效果。
Objective To observe the long term efficacy of Betaloc in patiens with chronic heart failure(CHF). Methods Forty-two patiens with chronic heart failure were randomly divided into two groups to accept either Betaloc (Betaloc group, n=22) or routine treatment (ROU group, n=20). Results In the two weeks of observation, there were a significant improvement of the heart function and a significant slowdown of the heart rate. Conclusion Betaloc is a medicine of high efficacy on the CHF in comparison with routine treatment.
出处
《中华临床医学卫生杂志》
2006年第10期38-39,共2页
China Journal of Clinical Medicine Hygiene